A phase II study of pemetrexed monotherapy in chemo-naïve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)
Crossref DOI link: https://doi.org/10.1007/s00280-015-2755-2
Published Online: 2015-04-30
Published Print: 2015-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hata, Akito
Katakami, Nobuyuki
Fujita, Shiro
Nanjo, Shigeki
Takeshita, Jumpei
Tanaka, Kosuke
Kaneda, Toshihiko
Nishiyama, Akihiro
Nishimura, Takashi
Nakagawa, Atsushi
Otsuka, Kojiro
Morita, Satoshi
Urata, Yoshiko
Negoro, Shunichi
Text and Data Mining valid from 2015-04-30